Basolateral targeting of ERBB2 is dependent on a novel bipartite juxtamembrane sorting signal but independent of the C-terminal ERBIN-binding domain

被引:36
|
作者
Dillon, C [1 ]
Creer, A [1 ]
Kerr, K [1 ]
Kümin, A [1 ]
Dickson, C [1 ]
机构
[1] Canc Res UK, Viral Carcinogenesis Lab, London Res Inst, Lincolns Inn Fields Labs, London WC2A 3PX, England
关键词
D O I
10.1128/MCB.22.18.6553-6563.2002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ERBB2 is a receptor tyrosine kinase present on the basolateral membrane of polarized epithelia and has important functions in organ development and tumorigenesis. Using mutagenic analyses and Madin-Darby canine kidney (MDCK) cells, we have investigated the signals that regulate basolateral targeting of ERBB2. We show that basolateral delivery of ERBB2 is dependent on a novel bipartite juxtamembrane sorting signal residing between Gln-692 and Thr-701. The signal shows only limited sequence homology to known basolateral targeting signals and is both necessary and sufficient for correct sorting of ERBB2. In addition we demonstrate that this motif can function as a dominant basolateral targeting signal by its ability to redirect the apically localized P75 neurotrophin receptor to the basolateral membrane domain of polarized epithelial cells. Interestingly, LLC-PK1 cells, which are deficient for the mu1B subunit of the AP1B adaptor complex, missort a large proportion of ERBB2 to the apical membrane domain. This missorting can be partially corrected by the introduction of mu1B, suggesting a possible role for AP1B in ERBB2 endosomal trafficking. Furthermore, we find that the C-terminal ERBIN binding domain of ERBB2 is not necessary for its basolateral targeting in MDCK cells.
引用
收藏
页码:6553 / 6563
页数:11
相关论文
共 25 条
  • [1] Signal transduction interactome associated to the unstructured C-terminal domain of ErbB2
    Feracci, M.
    Bornet, O.
    Nouailler, M.
    Badache, A.
    Guerlesquin, F.
    FEBS JOURNAL, 2011, 278 : 209 - 209
  • [2] Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma
    Chougoni, Kranthi Kumar
    Park, Haemin
    Damle, Priyadarshan K.
    Mason, Travis
    Cheng, Bo
    Dcona, Martin M.
    Szomju, Barbara
    Dozmorov, Mikhail G.
    Idowu, Michael O.
    Grossman, Steven R.
    ONCOGENESIS, 2023, 12 (01)
  • [3] Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma
    Kranthi Kumar Chougoni
    Haemin Park
    Priyadarshan K. Damle
    Travis Mason
    Bo Cheng
    Martin M. Dcona
    Barbara Szomju
    Mikhail G. Dozmorov
    Michael O. Idowu
    Steven R. Grossman
    Oncogenesis, 12
  • [4] C-terminal Binding Protein (CtBP): a critical regulator of ErbB2/3 signaling in PDAC.
    Chougoni, Kranthi Kumar
    Park, Haemin
    Damle, Priyadarshan K.
    Dcona, Martin Michael
    Szomju, Barbara
    Dozmorov, Mikhail G.
    Idowu, Michael
    Grossman, Steven R.
    CANCER RESEARCH, 2022, 82 (22) : 106 - 106
  • [5] Identification of a Src kinase SH3 binding site in the C-terminal domain of the human ErbB2 receptor tyrosine kinase
    Bornet, Olivier
    Nouailler, Matthieu
    Feracci, Michael
    Sebban-Kreuzer, Corinne
    Byrne, Deborah
    Halimi, Hubert
    Morelli, Xavier
    Badache, Ali
    Guerlesquin, Francoise
    FEBS LETTERS, 2014, 588 (12): : 2031 - 2036
  • [6] LIGAND-DEPENDENT BIPARTITE NUCLEAR TARGETING SIGNAL IN THE HUMAN ANDROGEN RECEPTOR - REQUIREMENT FOR THE DNA-BINDING DOMAIN AND MODULATION BY NH2-TERMINAL AND CARBOXYL-TERMINAL SEQUENCES
    ZHOU, ZX
    SAR, M
    SIMENTAL, JA
    LANE, MV
    WILSON, EM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (18) : 13115 - 13123
  • [7] Identification of an atypical calcium-dependent calmodulin binding site on the C-terminal domain of GluN2A
    Bajaj, Gaurav
    Hau, Andrew M.
    Hsu, Peter
    Gafken, Philip R.
    Schimerlik, Michael I.
    Ishmael, Jane E.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 444 (04) : 588 - 594
  • [8] Penicisulfuranol A, a novel C-terminal inhibitor disrupting molecular chaperone function of Hsp90 independent of ATP binding domain
    Dai, Jiajia
    Chen, Ao
    Zhu, Meilin
    Qi, Xin
    Tang, Wei
    Liu, Ming
    Li, Dehai
    Gu, Qianqun
    Li, Jing
    BIOCHEMICAL PHARMACOLOGY, 2019, 163 : 404 - 415
  • [9] A novel cellular phenotype in Nephrogenic Diabetes Insipidus: Targeting of wild-type Aquaporin-2 to the Basolateral Membrane after heterotetramerization with an Aquaporin-2 mutant containing two C-terminal basolateral targeting motifs
    Kamsteeg, EJ
    Bichet, DG
    Konings, IBM
    Nivet, H
    Arthus, MF
    Lonergan, M
    Waaijenborg, S
    van der Sluijs, P
    van Os, CH
    Deen, PMT
    MOLECULAR BIOLOGY OF THE CELL, 2001, 12 : 346A - 346A
  • [10] C-terminal binding protein 2 is a novel tumor suppressor targeting the MYC-IRF4 axis in multiple myeloma
    Cheung, Coty Hing Yau
    Cheng, Chi Keung
    Leung, Kam Tong
    Zhang, Chi
    Ho, Chi Yan
    Luo, Xi
    Kam, Angel Yuet Fong
    Xia, Tian
    Wan, Thomas Shek Kong
    Pitts, Herbert Augustus
    Chan, Natalie Pui Ha
    Cheung, Joyce Sin
    Wong, Raymond Siu Ming
    Zhang, Xiao-Bing
    Ng, Margaret Heung Ling
    BLOOD ADVANCES, 2024, 8 (09) : 2217 - 2234